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Abstract
Background: Eukaryotic translation elongation factor eEF1A directs the correct aminoacyl-tRNA
to ribosomal A-site. In addition, eEF1A is involved in carcinogenesis and apoptosis and can interact
with large number of non-translational ligands.
There are two isoforms of eEF1A, which are 98% similar. Despite the strong similarity, the isoforms
differ in some properties. Importantly, the appearance of eEF1A2 in tissues in which the variant is
not normally expressed can be coupled to cancer development.
We reasoned that the background for the functional difference of eEF1A1 and eEF1A2 might lie in
changes of dynamics of the isoforms.
Results:  It has been determined by multiple MD simulation that eEF1A1 shows increased
reciprocal flexibility of structural domains I and II and less average distance between the domains,
while increased non-correlated diffusive atom motions within protein domains characterize
eEF1A2. The divergence in the dynamic properties of eEF1A1 and eEF1A2 is caused by interactions
of amino acid residues that differ between the two variants with neighboring residues and water
environment.
The main correlated motion of both protein isoforms is the change in proximity of domains I and
II which can lead to disappearance of the gap between the domains and transition of the protein
into a "closed" conformation. Such a transition is reversible and the protein can adopt an "open"
conformation again. This finding is in line with our earlier experimental observation that the
transition between "open" and "closed" conformations of eEF1A could be essential for binding of
tRNA and/or other biological ligands.
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The putative calmodulin-binding region Asn311-Gly327 is less flexible in eEF1A1 implying its
increased affinity for calmodulin. The ability of eEF1A1 rather than eEF1A2 to interact with Ca2+/
calmodulin is shown experimentally in an ELISA-based test.
Conclusion: We have found that reversible transitions between "open" and "close" conformations
of eEF1A provide a molecular background for the earlier observation that the eEF1A molecule is
able to change the shape upon interaction with tRNA. The ability of eEF1A1 rather than eEF1A2
to interact with calmodulin is predicted by MD analysis and showed experimentally. The differential
ability of the eEF1A isoforms to interact with signaling molecules discovered in this study could be
associated with cancer-related properties of eEF1A2.
Background
Higher eukaryotic translation elongation factor eEF1A
operates in translation cycles by directing the correct ami-
noacyl-tRNA to the A site of mRNA-programmed ribos-
ome [1]. A further translational function could be the
interaction of eEF1A with deacylated tRNA coupled with
direct transfer of tRNA in the channeled elongation steps
of mammalian translation [2]. Besides its role in transla-
tion, eEF1A is involved in other cellular processes such as
carcinogenesis and apoptosis and can interact with a large
number of non-translational ligands in the cell [3,4].
There are two tissue and developmental-specific isoforms
of eEF1A, which are 93% identical and 98% similar [5].
Importantly, despite the strong similarity of sequence at
the amino acid level, the isoforms appear to differ in some
properties and functions, which are both related and
unrelated to translation. For example, the eEF1A2 isoform
has a higher affinity for GDP than for GTP, whilst the
affinity of eEF1A1 for these ligands is similar [5]. In the
presence of eEF1A2 an inhibition of apoptotic processes
was observed, whilst the opposite was found for eEF1A1
[6]. Importantly, the appearance of eEF1A2 in tissues in
which the variant is not normally expressed can be cou-
pled to cancer development, as shown for ovary and sug-
gested in some cases of breast cancer [7-9]. Importantly,
eEF1A1 serves as a housekeeping protein in the same tis-
sues and seemingly is not related to the cancer in these
cases. The structural peculiarities which underlay the can-
cer specificity of eEF1A2 remain unknown. The eEF1A1
and eEF1A2 isoforms contain 462 and 463 amino acid
residues respectively with 34 replacements and a sole
deletion of the penultimate residue in eEF1A1 (Figure 1).
eEF1A1 has seven modified residues: N-trimethyllysines
(M3l) 36, 79 and 318, N-dimethyllysines (Mly) 55 and
165, L-glutamyl 5-glycerylphosphorylethanolamines
(GPE) 301 and 374 [10]. The eEF1A2 molecule is charac-
terized by four modified residues (M3l55 and 165,
GPE301 and 374), however, complete analysis of the
eEF1A2 post-translation modifications is lacking [5].
Since the functional difference of the isoforms cannot be
attributed to the any amino acid substitutions at our cur-
rent level of knowledge, we reasoned that the background
for the functional difference of eEF1A1 and eEF1A2 might
lie in changes of spatial structure of the proteins.
Higher eukaryotic eEF1A has so far been resistant to
attempts to crystallize it, so X-ray analysis is available only
for the complex of yeast eEF1A with the truncated GDP
exchange subunit eEF1Ba [11,12]. The identity of yeast
and human eEF1A is more than 80%, so we modeled the
spatial structures of human eEF1A1 and eEF1A2 using this
X-ray structure as the main template. Not surprisingly, no
meaningful difference in the static structures of eEF1A1
[see Additional file 1] and eEF1A2 [see Additional file 2]
was found by this approach. In spite of this, it was tempt-
ing to analyze the molecular dynamics (MD) of the iso-
forms. In this case, initial models similar for both
isoforms could be developed in the course of MD simula-
tion into noticeably different conformations of the
eEF1A1 and eEF1A2 molecules.
Complete conformational sampling for a three-domain
protein may require an MD trajectory of a relatively long
time scale. However, the protein can adopt denatured
forms during simulation, and if the only trajectory is avail-
able, the denatured state can be interpreted as the native
conformation in solution. Moreover, statistical errors
accumulate at long MD calculation. In view of the afore-
said, an alternative, multiple MD simulation method
[13,14] has been used. The method consists of the simu-
lation of several relatively short MD trajectories starting
from the same initial protein conformation with different
initial atom velocities. Multiple MD simulation permits a
reduction of computational time, a widening of the statis-
tical basis, and allows us to evaluate quality of single tra-
jectories and minimize force-field induced artifacts
[15,16].
Our multiple MD simulation studies demonstrated more
inter-domain mobility of the eEF1A1 molecule when
compared to eEF1A2. At the same time eEF1A2 was char-
acterized by a higher internal mobility of the structural
domains. Amino acid residues were determined, for
which flexibility is evidently different in the isoforms.
Some significant MD characteristics inherent to both iso-BMC Structural Biology 2008, 8:4 http://www.biomedcentral.com/1472-6807/8/4
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Alignment of the sequences of elongation factors 1A Figure 1
Alignment of the sequences of elongation factors 1A. eEF1A1 – human eEF1A1 [Swiss-Prot: ], eEF1A2 – human eEF1A2 
[Swiss-Prot: ], Yeast – yeast eEF1A [Swiss-Prot: ], S. Solfataricus – aEF1A of Sulfolobus solfataricus [Swiss-Prot: ], T. Aquaticus 
– EF-Tu of Termus Aquaticus [Swiss-Prot: ]. Replacements and deletion in eEF1A1 and eEF1A2 are marked in red.
eEF1A1         1         MGKEK THINIVVIGH VDSGKSTTTG HLIYKCGGID KRTIEKFEKE 
eEF1A2         1         MGKEK THINIVVIGH VDSGKSTTTG HLIYKCGGID KRTIEKFEKE 
Yeast          1         MGKEK SHINVVVIGH VDSGKSTTTG HLIYKCGGID KRTIEKFEKE 
S.Solfataricus 1         MS-QK PHLNLIVIGH VDHGKSTLVG RLLMDRGFID EKTV-KEAEE 
T. Aquaticus   1    MAKGEFIRTK PHVNVGTIGH VDHGKTTLTA ALTFVT---- ---------- 
eEF1A1         47   AAE-MGKGSF KYAWVLDKLK AERERGITID ISLWKFETSK YYVTIIDAPG 
eEF1A2         47   AAE-MGKGSF KYAWVLDKLK AERERGITID ISLWKFETTK YYITIIDAPG 
Yeast          47   AAE-LGKGSF KYAWVLDKLK AERERGITID IALWKFETPK YQVTVIDAPG 
S.Solfataricus 45   AAKKLGKESE KFAFLLDRLK EERERGVTIN LTFMRFETKK YFFTIIDAPG 
T. Aquaticus   37   AAE-NPNVEV KDYGDIDKAP EERARGITIN TAHVEYETAK RHYSHVDCPG 
eEF1A1         96   HRDFIKNMIT GTSQADCAVL IVAAGVGEFE AGISKNGQTR EHALLAYTLG 
eEF1A2         96   HRDFIKNMIT GTSQADCAVL IVAAGVGEFE AGISKNGQTR EHALLAYTLG 
Yeast          96   HRDFIKNMIT GTSQADCAIL IIAGGVGEFE AGISKDGQTR EHALLAFTLG 
S.Solfataricus 95   HRDFVKNMIT GASQADAAIL VVSAKKGEYE AGMSVEGQTR EHIILAKTMG 
T. Aquaticus   86   HADYIKNMIT GAAQMDGAIL VVSAADGPMP -------QTR EHILLARQVG 
eEF1A1         146  VKQLIVGVNK MDSTEPPYSQ KRYEEIVKEV STYIKKIGYN PDTVAFVPIS 
eEF1A2         146  VKQLIVGVNK MDSTEPAYSE KRYDEIVKEV SAYIKKIGYN PATVPFVPIS 
Yeast          146  VRQLIVAVNK MDSVK--WDE SRFQEIVKET SNFIKKVGYN PKTVPFVPIS 
S.Solfataricus 145  LDQLIVAVNK MDLTEPPYDE KRYKEIVDQV SKFMRSYGFN TNKVRFVPVV 
T. Aquaticus   129  VPYIVVFMNK VDMV----DD PELLDLV-EM EVRDLLNQYE -FPGDEVPVI 
eEF1A1         196  GWNGDNMLEP SANMPWFKGW KVTRKDGNAS GTTLLEALDC ILP-PTRPTD 
eEF1A2         196  GWHGDNMLEP SPNMPWFKGW KVERKEGNAS GVSLLEALDT ILP-PTRPTD 
Yeast          194  GWNGDNMIEA TTNAPWYKGW EKETKAGVVK GKTLLEAIDA IEQ-PSRPTD 
S.Solfataricus 195  APSGDNITHK SENMKWYNGP TLEE------ ------YLDQ LEL-PPKPVD 
T. Aquaticus   173  RGSALLALEE MHKNP--KTK RGEN-EWVDK IWELLDAIDE YIPTPVRDVD 
eEF1A1         245  KPLRLPLQDV YKIGGIGTVP VGRVETGVLK PGMVVTF--- APVNVTTEVK 
eEF1A2         245  KPLRLPLQDV YKIGGIGTVP VGRVETGILR PGMVVTF--- APVNITTEVK 
Yeast          243  KPLRLPLQDV YKIGGIGTVP VGRVETGVIK PGMVVTF--- APAGVTTEVK 
S.Solfataricus 232  KPLRIPIQDV YSISGVGTVP VGRVESGVLK VGDKIVF--- MPAGKVGEVR 
T. Aquaticus   220  KPFLMPVEDV FTITGRGTVA TGRIERGKVK VGDEVEIVGL APETRKTVVT 
eEF1A1         292  SVEMHHEALS EALPGDNVGF NVKNVSVKDV RRGNVAGDSK NDPPMEAAGF 
eEF1A2         292  SVEMHHEALS EALPGDNVGF NVKNVSVKDI RRGNVCGDSK SDPPQEAAQF 
Yeast          290  SVEMHHEQLE QGVPGDNVGF NVKNVSVKEI RRGNVCGDAK NDPPKGCNAS 
S.Solfataricus 279  SIETHHTKMD KAEPGDNIGF NVRGVEKKDI KRGDVVG-HP NNPPTVADEF 
T. Aquaticus   270  GVEMHRKTLQ EGIAGDNVGL LLRGVSREEV ERGQVL--AK PGSITPHTKF 
eEF1A1         342  TAQVIIL--- ---NHPGQIS AGYAPVLDCH TAHIACKFAE LKEKIDRRSG 
eEF1A2         342  TSQVIIL--- ---NHPGQIS AGYSPVIDCH TAHIACKFAE LKEKIDRRSG 
Yeast          340  FATVIVL--- ---NHPGQIS AGYSPVLDCH TAHIACRFDE LLEKNDRRSG 
S.Solfataricus 328  TARIIVV--- ---WHPTALA NGYTPVLHVH TASVACRVSE LVSKLDPRTG 
T. Aquaticus   318  EASVYVLKKE EGGRHTGFFS -GYRPQFYFR TT-------- -----DVTGV 
eEF1A1         386  KKLEDGPKFL KSGDAAIVDM VPGKPMCVES FSDYPPLGRF AVRDMRQTVA 
eEF1A2         386  KKLEDNPKSL KSGDAAIVEM VPGKPMCVES FSQYPPLGRF AVRDMRQTVA 
Yeast          384  KKLEDHPKFL KSGDAALVKF VPSKPMCVEA FSEYPPLGRF AVRDMRQTVA 
S.Solfataricus 372  QEAEKNPQFL KQGDVAIVKF KPIKPLCVEK YNEFPPLGRF AMRDMGKTVG 
T. Aquaticus   354  VRLPQGVEMV MPGDNVTFTV ELIKPVALE- --E--GL-RF AIREGGRTV- 
eEF1A1         436  VGVIKAVDKK AAGAGKVTKS AQKAQKA-K
eEF1A2         436  VGVIKNVEKK SGGAGKVTKS AQKAQKAGK
Yeast          434  VGVIKSVDK- TEKAAKVTKA AQKAAK--K
S.Solfataricus 422  VGIIVDVKP- ----AKVEIK
T. Aquaticus   396  ---------- --GAGVVTKI LE BMC Structural Biology 2008, 8:4 http://www.biomedcentral.com/1472-6807/8/4
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forms were also revealed; in particular, fluctuation of the
eEF1A molecule between "open" and "closed" conforma-
tions in solution was shown providing for the first time a
description of the dynamic behavior of human eEF1A in
solution. Importantly, a difference in putative calmodulin
binding sites of the isoforms has been predicted. The data
obtained are an essential step in the move towards an
understanding of the functional divergence of the near-
identical eEF1A1 and eEF1A2 isoforms, and in particular,
the cancer-related properties of the latter.
Results and Discussion
The models consist of three domains (Figure 2a). The first
domain contains 8 β-strands (Thr6-Ile13, Trp78-Thr82,
Tyr85-Ala92, Cys111-Ala118, Gln147-Asn153, Ala189-
Ile193, Trp214-Arg218 and Gly221-Gly225), which form
the β-sheet surrounded by 8 α-helices (Lys20-Lys30, M3l/
Lys36-Glu48, Ala57-Glu68, Asp97-Thr104, Val120-
Ala125, Thr133-Leu143, Gln164-Ile181 and Leu228-
Asp233). The second domain is the β-barrel formed by the
strands Leu248-Leu250, Asp252-Ile256, Gly260-Val267,
Met276-Ala281, Val/Ile285-Val289, Ser291-Met294,
Glu297-Leu299, Asp306-Val312 and Asn324-Ser329. The
third domain is also in the β-barrel consisting of β-strands
Gly/Gln339-Leu347, Tyr357-Cys363, Ala366-Asp380,
Lys385-Gly/Asn390, Asp398-Gly407, Gly422-Asp428
and Gln431-Asp/Glu442. In the present study the resi-
dues up to Pro238 are attributed to domain I, because
Pro238 is the last residue from the continuous series of
residues in the unstructured chain Cys234-Arg247, which
are situated within the distance of the van der Waals radii
sum to a residue from the other chain of the domain I
(Asp110 for Pro238). Similarly, Pro241 is the first residue
from the chain Cys234-Arg247, which is within the dis-
tance of the van der Waals radii sum from a residue of
other chain of the domain II (Gly270), so Pro241 is cho-
sen as the first residue of the domain II. Ser329 is the end
of the domain II because it is the last residue in the
Asn324-Ser329  β-strand. Domain III starts with Met/
Gln335, which is situated within the distance of the van
der Waals radii sum from a residue of other chain of the
domain III (Cys411). Domains I and III and also domains
II and III are situated tightly one to another, while a volu-
minous space exists between domains I and II. The space
is limited by loop Arg69-Leu77 from the side of domain I
and by residues His295-Gly305 from the side of domain
II.
Table 1 demonstrates that the average rmsd of eEF1A1 is
somewhat larger than rmsd of eEF1A2, consequently, the
final solution conformation of eEF1A1 moves further
away from the conformation of the initial model. Besides,
since eEF1A1 rmsd is characterized by a larger σ value
than rmsd of eEF1A2, the eEF1A1 molecule should have
more conformational space than eEF1A2.
In contrast to the full protein rmsd, the rmsds of separate
domains show more scattering (more σ) for eEF1A2 than
for eEF1A1. So, the internal motions of the domains are
larger in the eEF1A2 molecule. The difference in mobility
of the two protein variants is mostly observed for domain
Ribbon representation of the eEF1A molecule Figure 2
Ribbon representation of the eEF1A molecule. a – 
domains I, II and III; 1 and 2 – amino acid residues Arg69-
Leu77 and His295-Gly305, which are on the surface of the 
gap between the domains I and II, 3 and 4 – motifs Asn311-
Gly327 and Gly422-Val437, suggested to be the calmodulin 
binding site in eEF1A1. b – amino acid residues with a posi-
tive difference between the rmsf of eEF1A2 and eEF1A1 of 
more than 0.02 nm (Met1-Lys5, Asp35-Glu48, Gly50-Thr58, 
Asp61, Lys62, Lys64-Glu68, Gly70-Asp74, Ala125-Ser128, 
Val216-Gly221, Ala223, Cys/Thr234, Gly258, Ile259, Pro282, 
His296-Ala298, Ser316, M3l318-Arg322, Gln352, His364, 
Thr365, Tyr418-Pro420, ribbon colored in red) and with 
negative differences of less than -0.02 nm (Asn130, Ser157, 
Lys313, Ser329, Ser383, Gly384, Glu388, Asp398, ribbon 
colored in blue); side chains of residues Asp197 and Mly55 
which stabilize the motif Asp35-Asp74 in eEF1A1 are shown.BMC Structural Biology 2008, 8:4 http://www.biomedcentral.com/1472-6807/8/4
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III [see Additional file 3]. One may conclude that domain
III of eEF1A2 moves in solution more away from the ini-
tial conformation than the same domain of eEF1A1. Thus,
for eEF1A1 an increased mobility of the entire protein
(inter-domain mobility) while for eEF1A2 an elevated
mobility of individual domains (internal domain mobil-
ity) are detected.
The distance between centers of the domains was calcu-
lated (Figure 3) to directly analyze the inter-domain
mobility of the isoforms. A direct link between the full
protein rmsd and the distance between the domains I and
II is observed for eEF1A1. The trajectories characterized by
the maximal rmsd for the full protein (6 and 1) [see Addi-
tional file 3] demonstrate the smallest distance between
domains I and II (Figure 3a). Similarly, the trajectories
with the minimal rmsd (2 and 4) show the maximal dis-
tance between the domains I and II. Consequently, the
departure of eEF1A1 from the initial conformation is
accompanied by the approaching of domains I and II.
The correlation for eEF1A2 is less obvious. Thus, trajectory
13 demonstrating the maximal full protein rmsd is char-
acterized by the minimal distance between the domains I
and II (Figure 3b), but trajectory 12 which displays the
elevated full protein rmsd is characterized by the largest
distance between domains I and II. So, for both variants
the correspondence between the maximal rmsd and the
minimal distance between the domains I and II is con-
served, while the correlation of the minimal rmsd and the
maximal distance between the domains is valid only for
eEF1A1. This confirms that the full protein rmsd scatter-
ing for eEF1A1 is determined mainly by the reciprocal
motions of the domains I and II, whereas the rmsd scatter-
ing for eEF1A2 is determined both by the inter-domain
and internal domain motions.
The average distance between domains I and II is less for
eEF1A1 (Figure 3c and Table 1). The distance between the
domains is decreased with simulation time for all trajecto-
ries of eEF1A1 (Figure 3a), while for eEF1A2 the abate-
ment is less substantial and is not observed for trajectories
10 and 12 (Figure 3b).
The distances between domains I and III and between
domains II and III change less significantly than distance
between domains I and II for both isoforms. However,
increased scattering (higher σ) of the distance between
domains I and III for eEF1A1 as compared to eEF1A2
should be noted (Table 1).
Interestingly, eEF1A1 has more inter-domain mobility but
less average distance between domains I and II, while
eEF1A2 is characterized by lower inter-domain mobility
but a larger average distance between the first and second
domains. For both protein variants the average protein
conformation is characterized by less distance between
domains I and II as compared to the initial model. In the
course of simulation the distance between the domains
decreases frequently and increases only rarely. That is why
the lower average distance between domains I and II
might be characteristic of a protein with higher inter-
domain mobility.
The increased proximity of the domains I and II causes a
decrease of the gap between the domains, i.e. between
chains Arg69-Leu77 of the domain I and His295-Gly305
of domain II (see Figure 2a). The minimal distance
between the chains decreases up to van der Waals radii
sum for trajectories 1 and 6 [see Additional file 4] of
eEF1A1 (Figure 3e) and for trajectories 7, 8, 13 [see Addi-
tional file 5] of eEF1A2 (Figure 3f) indicating the forma-
tion of a "completely closed" conformation. This
Table 1: Average values and root-mean-square fluctuations of parameters calculated from MD trajectories after 4000 ps
Parameter eEF1A1 eEF1A2
M ± 2 m σ M ± 2 m σ
Cα-atoms trace rmsd for full protein 0.36540 ± 0.00058 0.05404 0.35817 ± 0.00045 0.04326
Cα-atoms trace rmsd for domain I 0.30890 ± 0.00026 0.02438 0.31012 ± 0.00040 0.03861
Cα-atoms trace rmsd for domain II 0.18125 ± 0.00030 0.02758 0.18347 ± 0.00042 0.04051
Cα-atoms trace rmsd for domain III 0.17547 ± 0.00014 0.01277 0.20157 ± 0.00024 0.02270
Distance between centers of the domains I and II for all trajectories 3.26007 ± 0.00193 0.17880 3.33949 ± 0.00196 0.18727
Distance between centers of the domains I and II excluding trajectories 1,6,7,8,13 
with "close" conformation for more than 500 ps
3.33688 ± 0.00159 0.11779 3.44489 ± 0.00212 0.14451
Distance between centers of the domains I and III 3.06352 ± 0.00087 0.08099 3.04624 ± 0.00069 0.06581
Distance between centers of the domains II and III 2.72471 ± 0.00050 0.04679 2.70452 ± 0.00048 0.04580
Cα-atoms trace rmsd of Asn311-Gly327 after fitting of domain II to the initial 
conformation
0.18791 ± 0.00025 0.02324 0.18904 ± 0.00045 0.04320
Cα-atoms trace rmsd of Gly422-Val437 after fitting of domain III to the initial 
conformation
0.17349 ± 0.00033 0.03101 0.19476 ± 0.00032 0.03070BMC Structural Biology 2008, 8:4 http://www.biomedcentral.com/1472-6807/8/4
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Distance between centers of domains I and II (a-d) and minimal distance between regions Arg69-Leu77 and His295-Gly305 (e,  f) Figure 3
Distance between centers of domains I and II (a-d) and minimal distance between regions Arg69-Leu77 and 
His295-Gly305 (e, f). a, e – eEF1A1: red – trajectory 1, green – trajectory 2, blue – trajectory 3, cyan – trajectory 4, magenta 
– trajectory 5, yellow – trajectory 6. b, f – eEF1A2: red – trajectory 7, green – trajectory 8, blue – trajectory 9, cyan – trajec-
tory 10, magenta – trajectory 11, yellow – trajectory 12, orange – trajectory 13. c – the mean distances between centers of the 
domains I and II for eEF1A1 (black) and eEF1A2 (red); averaging has been done for all respective trajectories. d – the mean dis-
tances between the centers of domains I and II after the exemption of the trajectories characterized by the existence of 
"closed" conformation for more than 500 ps (1, 6 for eEF1A1 and 7, 8, 13 for eEF1A2).BMC Structural Biology 2008, 8:4 http://www.biomedcentral.com/1472-6807/8/4
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conformation is characterized by a high full protein rmsd
with respect to the initial protein conformation and by a
large number of contacts between the Arg69-Leu77 and
His295-Gly305 groups.
The proteins can oscillate from an extended to a compact
conformation and vice versa. For example, trajectory 6
moves to a "closed" conformation of a protein at 1300 ps,
then returns to an "open" conformation at 2900 ps, and
again transforms into a "closed" one at 4300 ps (Figure
3e,g). Trajectories 5, 9 and 12 adopt a "closed" conforma-
tion of a protein only for a short time at 8500–8600,
6350–6650 and 7500–7900 ps, respectively (Figure 3e–
h). Critically, it has been demonstrated recently by small
angle neutron scattering experiments that eEF1A1 adopts
an "extended" conformation in solution, becoming more
compact in the presence of tRNA [17]. Thus, one may sug-
gest that the short-lived "closed" conformation of eEF1A
found by MD simulation analysis can be stabilized by its
biological ligands.
Importantly, the distance between the domains I and II
remains closer for eEF1A1 than for eEF1A2 even after
omitting from the calculations the trajectories which
adopt a "closed" conformation for more than 500 ps (1, 6
for eEF1A1 and 7, 8, 13 for eEF1A2) (Figure 3d). Thus, the
average distance between domains I and II is less in the
eEF1A1 than in eEF1A2 "open" conformations. Since the
region of the cleft between the domains I and II could be
important for tRNA binding, at least for prokaryotic EF-Tu
[18,19], it is reasonable to assume that the tRNA affinity
for eEF1A1 and eEF1A2 could differ.
To describe the correlated motions of the protein
domains, a covariance analysis of Cα-atoms was per-
formed (see Methods). Trajectories 2 [see Additional file
6], 4 and 5 for eEF1A1 and 9 [see Additional file 7], 11
and 12 for eEF1A2 were chosen as the most stable trajec-
tories by Cα-atoms rmsd matrices. It was determined that
the ranges 2500–10466, 5440–10514, 3960–9920,
1070–10000, 3780–10417 and 1130–10197 ps chosen
for trajectories 2, 4, 5, 9, 11 and 12 respectively, contain
protein conformations with minimal rmsds with respect
to each other. The eigenvalues and cosine contents for
projections of the trajectories onto first eight eigenvectors
are listed in Table 2. Table 2 shows that the principal com-
ponents are well defined for the trajectory 2 of eEF1A1.
For other trajectories and especially for the trajectory 11 of
eEF1A2 the cosine content for the eigenvector 1 is rela-
tively high, so the estimations of the correlated motions
for these trajectories are more approximate. In fact, this
may provide further evidence that eEF1A2 has more intra-
domain non-correlated diffusive motions than eEF1A1.
As can be seen from Figure 4, the main correlated motions
for both isoforms are characterized by an increased prox-
imity of the domains I and II (first principal components
of trajectories 2, 5, 9, 11 and 12 and second principal
Table 2: First eight eigenvalues and cosine contents for the trajectories 2, 4, 5, 9, 11 and 12
Isoform eEF1A1 eEF1A2
Trajectory; time interval 2; 2500–10466 ps 4; 5440–10514 ps 5; 3960–9920 ps 9; 1070–10000 ps 11; 3780–10417 ps 12; 1130–10197 ps
Number of eigenvector Eigenvalue
1 2.92577 1.44506 2.00650 2.27184 2.30533 2.15311
2 1.68434 0.86893 1.36554 1.28574 0.78048 1.77254
3 0.68870 0.38034 0.47608 0.73461 0.46551 0.64839
4 0.46802 0.27333 0.29183 0.50336 0.29763 0.46346
5 0.32693 0.23964 0.26331 0.42775 0.27844 0.43969
6 0.28298 0.18535 0.22431 0.23191 0.20223 0.27086
7 0.18644 0.14662 0.15777 0.20346 0.18002 0.25996
8 0.16773 0.10737 0.13055 0.17295 0.16660 0.22564
Cosine content
1 0.03374 0.60652 0.63817 0.62554 0.89852 0.50174
2 0.02503 0.07350 0.52379 0.04251 0.22506 0.27044
3 0.00185 0.18572 0.25656 0.06206 0.00093 0.15005
4 0.00111 0.04537 0.30264 0.07576 3.209·10-7 0.02686
5 0.02844 0.00041 0.23341 0.19980 0.116878 0.00641
6 0.02734 0.03769 0.12111 0.07724 0.00179 0.10954
7 0.11791 0.00358 0.02747 0.02094 0.11159 0.02160
8 0.02168 0.16876 0.01118 0.08322 0.00296 0.11837BMC Structural Biology 2008, 8:4 http://www.biomedcentral.com/1472-6807/8/4
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Main correlated motions of two isoforms of human translation elongation factor 1A Figure 4
Main correlated motions of two isoforms of human translation elongation factor 1A. a-i – eEF1A1, j-r – eEF1A2. a-
c – 2500–10466 ps of trajectory 2; d-f – 5440–10514 ps of trajectory 4; g-i – 3960–9920 of trajectory 5; j-l – 1070–10000 ps of 
trajectory 9; m-o – 3780–10417 ps of trajectory 11; p-r – 1130–10197 ps of trajectory 12. a, d, g, j, m, p – first eigenvector; b, 
e, h, k, n, q – second eigenvector; c, f, i, l, o, r – third eigenvector. The protein regions of the maximal Cα-atom displacements 
(> 0.05 nm) are colored in black. The motions are shown on the average protein conformations in the respective trajectory 
ranges.BMC Structural Biology 2008, 8:4 http://www.biomedcentral.com/1472-6807/8/4
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components of trajectories 5, 9 and 11, Figure
4a,e,g,h,j,k,m,p) and by rotation of the structural domains
around diverse axes. The domain II and "top" part of
domain I (tail Met1-Lys5, helices M3l/Lys36-Glu48,
Ala57-Glu68 and loops Cys31-Asp32, Met49-Tyr56,
Arg69-Leu77) are most movable. In a number of cases
"top" part of the domain I moves independently from the
remaining part of the domain I (Figure 4a,b,f,i,k,l,n,o,q).
In some cases the domains II and III rotate as a single
whole around the same axis (Figure 4c,d,e,g,j,n).
Thus, we conclude that the main correlated motions of
the two eEF1A isoforms are similar: the coming together
of the domain II and the "top" part of domain I as well as
rotation of structural domains.
To characterize the random, non-correlated motions of
Cα-atoms, the rmsf of these atoms were calculated for the
separate domains in the 6000 ps trajectory ranges: 4000–
10000 ps for trajectories 1, 2, 4, 6, 7, 8, 9, 11, 12 and 13,
1110–7110 ps for trajectory 3 and 3920–9920 ps for tra-
jectory 5. The data were averaged for each variant (Figure
5). Figure 5 a demonstrates that the maximal flexibility of
Cα-atoms is typical for the loops, the "top" part of the
domain I and the "bottom" of domain III (Pro350-
Gln352, Arg381-Gly/Asn390). The residues for which a
difference between the rmsf of eEF1A2 and eEF1A1 is
more than 0.02 nm are labeled in red in Figure 2B, while
residues with the negative difference less than -0.02 nm
are labeled in blue.
Calmodulin binding
The importance of the data obtained for providing an
explanation of the possible functional dissimilarity of the
isoforms can be demonstrated by analysis of the putative
calmodulin binding site. It is known that plant and Tet-
rahymena eEF1A are calmodulin-binding proteins
[20,21]. Amino acid residues Asn311-Gly327, Gly422-
Val437 in eEF1A1 and Arg427-Val437 in eEF1A2 (Figure
1a) are predicted by the Calmodulin Target Database
(CTD) program [22] to be a possible calmodulin-binding
site of human eEF1A. The amino acid residues comprising
putative calmodulin binding site are well conserved from
human to yeast (Figure 6), this finding is in line with func-
tional importance of the site.
The Asn311-Gly327 motif is situated in domain II and
contains an unfolded loop Lys313-Gly323 flanked by
parts of neighboring β-strands. Because the Val325-
Gly327 region has no solvent accessible surface, only res-
idues Asn311-Asn324 could participate in calmodulin
binding if no essential conformational changes of domain
II take place during protein-protein interaction.
It was recently suggested that calmodulin-binding motifs
in a protein should be disordered or flanked by disor-
dered regions, adopting the most appropriate conforma-
tion for interaction with calmodulin [23]. Because region
Lys313-Gly323 is disordered, the motif Asn311-Gly327
satisfies the criterion for calmodulin-binding targets [23].
On the other hand, the binding process is most favorable
by entropy when the protein loses a minimal number of
degrees of freedom, i.e. when the binding motif has min-
imal diffusive non-correlated motions before the binding.
Thus, ordered regions such as α-helices flanked by disor-
dered regions reveal an especially high inclination for cal-
modulin binding [23]. Figure 5b II shows that residues
Val315-Val325 are more flexible in eEF1A2 than in
eEF1A1 (with a difference between the rmsf of eEF1A2
and eEF1A1 of more than 0.01). Besides, the Cα-atoms
rmsds of the motif Asn311-Gly327 during the fitting of
domain II to the initial conformation are more scattered
in eEF1A2 than in eEF1A1 (Figure 7a,b and Table 1), so
the diffusive motions of the motif residues are larger in
the second isoform. Thus, the region Asn311-Gly327
could bind calmodulin more tightly in eEF1A1 than in
eEF1A2.
As for the second putative calmodulin-binding motif, the
region of Gly422-Val437 is situated on the interface
between domains I and III and comprises a β-hairpin. The
region is essentially buried and only residues Arg427-
Gln431 have enough surface area accessible for interac-
tion with other proteins. Therefore we believe the motif
Gly422-Val437 has limited ligand binding capacity
which, however, can be increased in the case of essential
changes in the mutual orientation of domains I and III.
Because inter-domain mobility is larger in eEF1A1 (Table
1), the reorientation of such domains is more likely to
happen in that isoform. Furthermore, less significant dif-
fusive mobility of Asp428 in eEF1A1 (Figure 5B III)
should favor higher calmodulin-binding ability of that
isoform.
Thus, the MD simulation analysis predicts that eEF1A1
isoform should have increased affinity for calmodulin.
The ability of eEF1A1 and eEF1A2 to bind calmodulin was
examined experimentally. An enzyme-linked immuno-
sorbent assay-based binding assay was used to compare
calmodulin-binding properties of the isoforms. eEF1A1 or
eEF1A2 were pre-absorbed in the wells of a microtiter
plate and Ca2+-calmodulin was added to compete with
anti-eEF1A antibodies. If calmodulin binding to eEF1A
challenges antibody binding the absorbance value is
decreased in the presence of calmodulin. Ca2+-calmodulin
was found to interact with the eEF1A1 isoform only (Fig-
ure 8), thus validating the MD simulation prediction. TheBMC Structural Biology 2008, 8:4 http://www.biomedcentral.com/1472-6807/8/4
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Root-mean-square fluctuations of C-alpha atoms of the two eEF1A isoforms Figure 5
Root-mean-square fluctuations of C-alpha atoms of the two eEF1A isoforms. Data are averaged for the trajectories 
1–6 of eEF1A1 and 7–9, 11–13 of eEF1A2. A – rmsf of eEF1A1 (black) and eEF1A2 (gray). B – difference between rmsf of 
eEF1A2 and eEF1A1. I – domain I, II – domain II, III – domain III.
binding of Ca2+-calmodulin to the eEF1A1 isoform was
concentration dependent and observed at a 6-fold molar
excess of calmodulin over eEF1A1. Importantly, no Ca2+-
calmodulin interaction with eEF1A2 was detected even at
30-fold excess of the ligand. Anti-eEF1A antibodies did
not show any affinity for Ca2+-calmodulin. The addition
of Ca2+ alone (in the absence of calmodulin) to compete
with anti-eEF1A antibodies did not interfere with the
absorbance.
Conclusion
The dynamic behavior of eEF1A – one of the main protein
components of the human translation machinery – has
been described for the first time. The existence of a revers-BMC Structural Biology 2008, 8:4 http://www.biomedcentral.com/1472-6807/8/4
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ible transition between "open" and "close" conforma-
tions of eEF1A gives a molecular background for the
demonstrated earlier ability of eEF1A to change shape
upon interaction with tRNA.
We showed how a tiny divergence in the amino acid
sequences of the protein variants possessing 98% similar-
ity could still lead to changes of the spatial structure and
dynamics of the isoforms.
Different affinity of the eEF1A1 and eEF1A2 isoforms for
the important signaling protein calmodulin has been pre-
dicted by MD data and demonstrated experimentally.
Thus, diverse dynamic structures of the isoforms could
alter the types of interaction with signaling proteins. This
finding gives important background information to con-
sider in the context of specific cancer-related properties of
eEF1A2 [7-9]. Experiments to inspect the MD results by a
number of biophysical and molecular biology methods
are now in progress.
Methods
The three-dimensional models of the two variants of
human eEF1A have been built by the Swiss-Model server
[24,25] using the crystallographic structures of elongation
factors 1A of yeast Saccharomyces cerevisiae [PDB: 1IJE,
PDB: 1IJF, PDB: 1G7C, PDB: 1F60] and archaebacteria
Sulfolobus solfataricus [PDB: 1JNY] as templates. The
identity of yeast eEF1A and human eEF1A1 and eEF1A2
variants is 80.7 and 79.6% respectively (Figure 1), and the
identity of archaebacterial and human eEF1A is 53.1% for
eEF1A1 and 52.2% for eEF1A2. It should be noted that the
only crystallographic structure of eukaryotic factor 1A
available is that of yeast eEF1A in the complex with part of
the eEF1Balpha molecule [11,12]. eEF1A was in nucleo-
tide-free form in the complex. We do not know at present
Conservation of exposed residues in putative calmodulin binding domain of the eEF1A homologues Figure 6
Conservation of exposed residues in putative calmodulin binding domain of the eEF1A homologues.
30-50    60-80   90-100
Homology, %
Organisms used for homology 
calculation
Mammalia (Homo sapiens)
Aves (Gallus gallus)
Reptilia (Pelodiscus sinensis)
Amphibia (Xenopus tropicalis)
Pisces (Danio rerio)
Insecta (Drosophila melanogaster)
Mollusca (Crassostrea gigas)
Crustacea (Artemia sp.)
Nematoda (Caenorhabditis elegans) 
Plantae (Arabidopsis thaliana)
Yeast (Saccharomyces cerevisiae) BMC Structural Biology 2008, 8:4 http://www.biomedcentral.com/1472-6807/8/4
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how the presence of a nucleotide would influence the
molecular dynamics studies. Meanwhile, contrary to
prokaryotic analogue EF-Tu, no marked difference
between GDP and GTP-bound conformations of eEF1A
was found [1]. Further studies are necessary to make more
definite conclusion.
The C-termini of yeast and archaebacterial elongation fac-
tors 1A are unstructured, and that is why amino acid resi-
dues homologous to residues 444–462 of the mammalian
eEF1A were not determined by X-ray diffraction
[11,12,26]. So the residues were not included in resulting
models.
Trimethylation of lysine residues 36, 79, 318 of eEF1A1
[10] and 55, 165 of eEF1A2 [5] was performed by replac-
ing of hydrogen atoms by methyl groups. Similarly, Lys55
and Lys165 of eEF1A1 were changed to N-dimethyl-
lysines. NH2-groups of Gln301 and Gln374 of both pro-
tein variants were replaced by
glycerylphosphoryletanolamines [5,10].
The procedure of MD simulation was performed as in
[27]. The simulation was done using the GROMACS 3.1.4
software package [28,29]. The GROMOS96 43a2 force
field [30] was modified by the inclusion of parameters for
N-methyllysine, N-dimethyllysine, N-trimethyllysine and
L-glutamyl 5-glycerylphosphorylethanolamine [see Addi-
tional files 8 and 9]. The GROMOS96 topology data for
the mentioned non-standard amino acid residues were
generated by the Dundee PRODRG2 Server [31,32].
Hydrogens were added to the non-carbon heavy atoms
using the pdb2gmx program of the GROMACS 3.1.4 pack-
age. The lysines, dimethyllysines, arginines and N-termi-
nal amine group were put in the protonated state with
charge +1. The carboxyl groups of aspartic and glutamic
acids and of the C-terminal residue are deprotonated and
charged negatively. The His7 residue of both variants is
protonated at the Nε position since in the case of Nδ pro-
tonation the hydrogen atom would be too close to CHδ of
Tyr86. His15, 95 and 197 are protonated at Nε because the
Nδ atoms of the residues can form hydrogen bonds with
hydrogens of NH-groups of Asp17 and Asp97 and with
hydroxyl hydrogen of Ser194, respectively. His26, His296
Comparison of Ca2+-calmodulin binding to eEF1A isoforms  by enzyme-linked immunosorbent assay-based binding assay Figure 8
Comparison of Ca2+-calmodulin binding to eEF1A 
isoforms by enzyme-linked immunosorbent assay-
based binding assay. 1 – eEF1A1, 2 – eEF1A2. Microtiter 
96-well plates (Dynatech microtiter) were coated with puri-
fied eEF1A1 or eEF1A2, and monoclonal anti-eEF1A antibody 
was added with or without increasing amounts of Ca2+-cal-
modulin.
Cα-atoms rmsd of Asn311-Gly327 after fitting of domains II  to the initial domain conformation Figure 7
Cα-atoms rmsd of Asn311-Gly327 after fitting of 
domains II to the initial domain conformation. a – 
eEF1A1: red – trajectory 1, green – trajectory 2, blue – tra-
jectory 3, cyan – trajectory 4, magenta – trajectory 5, yellow 
– trajectory 6. b – eEF1A2: red – trajectory 7, green – trajec-
tory 8, blue – trajectory 9, cyan – trajectory 10, magenta – 
trajectory 11, yellow – trajectory 12, orange – trajectory 13. 
Black – average curves.BMC Structural Biology 2008, 8:4 http://www.biomedcentral.com/1472-6807/8/4
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and His367 are protonated at Nδ, allowing the electro-
static interaction of the protons with carbonyl oxygens of
the same residues. His136 is protonated at the Nδ position
that allows the Nε atom to form a H-bond with amide
hydrogen of the Gln132 side chain. His295 of both eEF1A
isoforms is protonated at ε-nitrogen, since that allows the
proton to interact with the Nε atom of His296. His349 is
protonated at the Nδ position, because if Nε is protonated,
it would be too close to Met429. His364 was determined
to be a Nδ-protonated residue since in that case the Nδ
hydrogen can interact with the sulfur atom of Cys363.
The protein models were inserted into the virtual boxes of
a truncated octahedron shape by the editconf program.
The minimal distance between the protein and the box
wall was 1.5 nm to prevent artificial periodicity [33,34]
and to allow the proteins to change conformations freely.
The box volumes were 1253.76 and 1303.49 nm3 for
eEF1A1 and eEF1A2, respectively. The difference in the
box volume sizes is explained by different orientation of
the GPE side chains and by the presence of differently
sized amino acid residues (Mly/M3l165, Ala/Pro206, Thr/
Glu217, Asp/Glu220, M3l/Lys318) at the eEF1A1 and
eEF1A2 surfaces. 39463 and 41270 SPC (Single Point
Charge) [35] water molecules were added into the boxes
containing the eEF1A1 and eEF1A2 variants respectively
(genbox program). The 69 and 72 water molecules were
replaced by sodium ions, whilst the 74 and 77 H2O mol-
ecules were replaced by chlorine ions for eEF1A1 and
eEF1A2 correspondingly, to neutralize the system and to
mimic the ionic force of 0.1 M (genion program). The
positions of the ions were chosen by the Poisson-Boltz-
mann distribution. The energy minimization of the sys-
tem was conducted by alternating steepest descent and
conjugative gradient algorithms up to the energy gradient
less than 100 kJ/(mol·nm). The solvent molecules equili-
bration was performed by the 500 ps MD simulation with
the protein atoms restrained to their positions. The initial
atom velocities were generated from the Maxwell's distri-
bution. Atoms coordinates were updated each 2·10-15 s.
The protein bonds were constrained by the linear con-
straint solver (LINCS) algorithm [36]. The cut-off for elec-
trostatic interaction was 0.9 nm. A double cut-off was
used for the Lenard-Jones interaction treatment. The inter-
actions between atoms within 0.9 nm were updated at
each step, and the interactions within the distance
between 0.9 and 1.4 nm were updated at each 10th step.
The Particle-mesh Ewald (PME) algorithm [37] was
applied to describe the long-range electrostatic interac-
tions. Temperature and pressure were kept at 298 K and 1
atmosphere using the Berendsen's method [38] with
relaxation times of 0.1 ps and 0.5 ps, respectively. After
equilibration of solvent molecules, additional energy
minimization of the system was carried out. Then, the
main MD simulation was performed with the same
parameters as the restrained simulation except the control
of pressure. The atom coordinates were written into the
output trajectory file every 1 ps.
Multiple MD simulation was performed. Six trajectories
were obtained for the eEF1A1 isoform: 1 (10000 ps), 2
(10466 ps), 3 (7110 ps), 4 (10514 ps), 5 (9920 ps) and 6
(10297 ps), while seven trajectories were simulated for
the eEF1A2 isoform: 7 (10000 ps), 8 (10000 ps), 9 (10000
ps), 10 (4015 ps), 11 (10417 ps), 12 (10197 ps), and 13
(10000 ps). The different initial velocities of atoms were
set for the different trajectories. The trajectory analysis was
performed using following parameters:
1) Cα-atoms trace root-mean-square deviation (rmsd)
after fitting to the initial conformation before the main
dynamics (g_rms program). Since the protein domains
can fluctuate relative to each other, the rmsd is calculated
both for the whole protein and for the separate domains.
To determine the flexibility of the putative calmodulin-
binding motifs (Asn311-Gly327 in domain II and
Gly422-Val437 in domain III) the fitting was done by Cα-
atoms of the respective domain and the rmsd was calcu-
lated for Cα-atoms of the calmodulin-binding motif.
2) The distances between the centers of the domains
(g_dist program). Centers of domains were calculated as
mean values of coordinates of Cα atoms of corresponding
domains.
Parameters 1) and 2) calculated from MD trajectories after
4000 ps were averaged for each eEF1A isoform and devia-
tions  σ  of the parameters were computed (Table 1).
Besides, deviations m of average values were calculated:
where n is total number of frames in all trajectories after
4000 ps for one isoform; n = 34307 and 36629 for eEF1A1
and eEF1A2, respectively. The Student's coefficient for a
0.05 significance level was taken as 2.
3) The minimal distance between the residues Arg69-
Leu77 and His295-Gly305 (g_mindist program).
4) The root-mean-square fluctuations (rmsf) of Cα-atoms
with respect to their average positions after fitting to the
initial conformation (g_rmsf program). This value was
calculated for the separate protein domains along trajec-
tory ranges of 6000 ps.
5) The analysis of the correlated motions of Cα-atoms
(g_covar, g_anaeig and g_analyse programs).
mn = σ , (1)BMC Structural Biology 2008, 8:4 http://www.biomedcentral.com/1472-6807/8/4
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Detailed examination of the correlated protein motions
has been conducted by Cα-atoms trace covariance analysis
[39] of the most stable trajectories. First of all, the Cα-
atoms rmsd matrices M are built using the g_rms program.
The matrices have a dimension n × n, where n is the
number of the trajectory frames (equal to the number of
picoseconds in the trajectory). Each matrix element Mi, j is
the rmsd between the protein conformations at time
moments i and j. The trajectory ranges presenting the con-
formations characterized by the least rmsd with respect to
each other have been determined. The covariance analysis
was performed for these trajectory ranges and the covari-
ance matrices C have been constructed:
where the arrows above the expressions denote vector val-
ues, the angle brackets – average values, the × sign is the
scalar product, x is the coordinate, t – time, k and l are one
of the space dimensions (x, y or z) for one of the atoms. So
the covariance matrices have 3 m × 3 m dimensions,
where m is the total number of Cα-atoms in the protein
model. If the two atoms move along the two dimensions
absolutely asynchronously, the matrix element is equal to
zero. If they move absolutely synchronously, the matrix
element corresponds to the atoms rmsf. As an atom
moves synchronously with itself, the covariance matrix
diagonal contains the corresponding atoms rmsf along
certain dimensions. The matrix C has been diagonalized
using orthonormal matrix R:
C = R·diag (λ1, λ2,..., λ3m)·RT,( 3 )
where the columns of matrix R are eigenvectors, which
correspond to eigenvalues λ, λ1 ≥ λ2 ≥ ... ≥ λ3m. The first
few eigenvectors (characterized by the largest eigenvalues)
often reflect collective global motions of the protein.
The quality of the covariance analysis must be controlled
to exclude interpretation of the random diffusion of
atoms as the correlated one. In the case of random diffu-
sion, the projection of the trajectory on eigenvector k
(called also the principal component) is the cosine with a
period of t∞·k/2, where t∞ is the length of the analyzed
part of the trajectory. That is why the cosine content of the
trajectory projections is calculated using the g_analyse
program. The cosine content is equal to 1 if the trajectory
projection is completely cosinusoid with the respective
period and the motions of atoms are completely random.
If the atom motions along respective eigenvectors are
completely correlated, the cosine content is zero. So the
cosine content can be considered as a fraction of the
atoms motion randomness.
The programs VMD [40] and Swiss-PDB Viewer [41] were
used for the trajectory visualization and graphical analysis
of the resulting conformations.
The eEF1A1 and eEF1A2 isoforms were isolated from rab-
bit liver and muscle respectively as described by us earlier
[42]. The activity of the eEF1A proteins was tested in a
GDP/[3H]GDP exchange test as in [43]. Calmodulin was
isolated from bovine brain according to conventional pro-
cedure [44].
In vitro binding of eEF1A (eEF1A1 and eEF1A2) with
Ca2+-calmodulin was measured by an indirect Enzyme-
linked Immunosorbent Assay using the procedure
described in [45]. Purified eEF1A*GDP (0,5 μg) in 100
mkl of TS buffer (30 mM Tris-HCl, pH 7,5; 10 mM KCl)
was coated overnight at 4°C in a 96-well polystyrene
microtiter plate (Dynatech microtiter). The wells were
rinsed five times with 200 μl of TS buffer. After blocking
with 200 μl of blocking buffer (0.1% bovine serum albu-
min in TS) for 1 h at room temperature and washing five
times with 200 μl of TS, 100 μl of 2000-fold-diluted in
blocking buffer mouse monoclonal anti-eEF1A antibody
and varying amounts of Ca2+-calmodulin (1, 5 μg, 5 μg,
10 μg and 50 μg) were added to wells and incubated at
room temperature for 2 h. Ca2+-calmodulin was prepared
by addition of CaCl2 to calmodulin (final concentration 1
mM) After washing five times with 200 μl of TS buffer,
100 μl of 5000-fold-diluted secondary goat anti-mouse
IgG antibody conjugated to horseradish peroxidase were
added per well and incubated for 1 h at room tempera-
ture. Then unbound antibodies were removed by five
washes of 200 μl of TS buffer. After addition of 100 μl of
ABTS (2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic
acid) at 0.5 mg/ml, the incubation proceeded at room
temperature for 10–15 min. The absorbance was esti-
mated at 405 nm in a Tecan Sunrise ELISA plate reader.
The experiments were performed several times to confirm
reproducibility.
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